IDEAYA Biosciences Inc.

NASDAQ: IDYA · Real-Time Price · USD
24.33
-0.04 (-0.16%)
At close: Aug 15, 2025, 3:59 PM
24.33
0.00%
After-hours: Aug 15, 2025, 04:54 PM EDT

IDEAYA Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-77.49M -72.18M -130.31M -51.82M -52.77M -39.57M -33.95M -27.44M -27.93M -23.64M -24.2M 1.61M -22.06M -14.01M -18.21M -11.58M -10.95M -9.02M
Depreciation & Amortization
1.23M 1.13M 643K 1.01M 1.1M 1.08M 1.02M 1.03M 998K 960K -492K 925K 1.2M 464K 448K 451K 444K 382K
Stock-Based Compensation
11.87M 10.24M 9.48M 9.21M 9.73M 6.31M 4.8M 5.3M 4.73M 3.66M 2.98M 3M 3.04M 2.6M 2.06M 2.2M 2.06M 1.92M
Other Working Capital
4.97M 1.52M 452K 1.68M 5.99M -4.87M -4.22M -1.38M -3.44M -7M -4.16M -26.02M -3.81M -10.32M -1.95M -7.96M -7.43M -6.2M
Other Non-Cash Items
9.18M -3.78M -4.92M -5.36M -4.42M 2.61M 33.95M -3.57M -2.55M -1.56M -1.13M -86K 169K 349K -330K -11.02M 445K 454K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -37.83M n/a n/a n/a n/a n/a n/a n/a 799K 11.49M n/a n/a
Change in Working Capital
4.61M 4.24M 3.44M -2.28M 15.7M -5.32M 8.26M -5.5M -8.71M -7.26M -525K -29.63M -2.35M -9.05M -1.43M -4M -4.93M -7.46M
Operating Cash Flow
-62.47M -60.34M -121.66M -49.23M -32.88M -43.81M -23.75M -30.17M -33.46M -27.84M -23.37M -24.17M -19.99M -19.65M -16.66M -12.47M -12.93M -13.72M
Capital Expenditures
-663K -1.33M -1.1M -457K -973K -1.32M -838K -603K -884K -43K n/a -1.1M -1.94M -401K -605K -458K -578K -1M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a 111.11M -51.95M 120.5M -23.56M n/a 17.58M -15.26M n/a n/a n/a n/a n/a
Purchase of Investments
-127.55M -105.21M -337.04M -213.72M -164.76M -475.78M -221.6M -81.83M -220.25M -72.3M -65.5M -88.08M -37.92M -64.3M -32.57M -149.38M -94.31M -38.74M
Sales Maturities Of Investments
174.13M 186.35M 141.03M 194.15M 234.29M 123.14M 110.5M 133.78M 99.75M 95.86M 55.23M 70.5M 53.18M 46.94M 32.76M 93.53M 45.51M 76.18M
Other Investing Acitivies
n/a n/a n/a n/a 69.53M -352.65M -111.11M 51.95M -120.5M 23.56M -10.28M -17.58M 15.26M -17.36M 192K -55.85M -48.8M 37.44M
Investing Cash Flow
45.92M 79.82M -197.11M -20.04M 68.56M -353.97M -111.94M 51.35M -121.38M 23.52M -10.28M -18.68M 13.32M -17.76M -413K -56.31M -49.38M 36.44M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -66K -9K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 1.13M 2.75M 11.84M 2.86M 5.46M 13.48M 1.85M 37.26M 366K 324K 147K 491K 653K 688K 808K 570K 112K
Financial Cash Flow
1.21M 26.14M 2.75M 286.5M 39.18M 349.11M 140.89M 27.83M 191.06M 2.93M 324K 95.7M 491K 653K 688K 86.78M 15.99M 42M
Net Cash Flow
-15.35M 45.62M -316.01M 218.15M 74.7M -48.67M 5.92M 49.01M 36.22M -1.4M -33.32M 52.85M -6.18M -36.76M -16.38M 18M -46.33M 64.72M
Free Cash Flow
-63.14M -61.67M -122.76M -49.69M -33.85M -45.14M -24.59M -30.78M -34.34M -27.89M -23.37M -25.27M -21.93M -20.05M -17.26M -12.93M -13.51M -14.73M